UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2025
Commission File Number: 001-42256
WORK
Medical Technology Group LTD
Floor 23, No. 2 Tonghuinan Road
Xiaoshan District, Hangzhou City, Zhejiang Province,
The People’s Republic of China
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F ☒ Form 40-F ☐
Explanatory Note
WORK Medical Technology Group LTD, a Cayman Islands
company (the “Company”), is furnishing its unaudited financial statements and notes for the six months ended March 31, 2025.
The financial statements and notes are attached as Exhibit 99.1 to this report. Management’s Discussion and Analysis of Financial
Condition and Results of Operations for the six months ended March 31, 2025 is attached as Exhibit 99.2 to this report.
Exhibit Index
Exhibit No. |
|
Description |
99.1 |
|
Unaudited Consolidated Financial Statements and Notes of WORK Medical Technology Group LTD for the Six Months Ended March 31, 2025 and 2024 |
99.2 |
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
101. INS |
|
Inline XBRL Instance Document |
101.SCH |
|
Inline XBRL Taxonomy Extension Schema Document |
101.CAL |
|
Inline XBRL Taxonomy Extension Calculation Linkbase Document |
101.DEF |
|
Inline XBRL Taxonomy Extension Definition Linkbase Document |
101.LAB |
|
Inline XBRL Taxonomy Extension Label Linkbase Document |
101.PRE |
|
Inline XBRL Taxonomy Extension Presentation Linkbase Document |
104 |
|
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
WORK Medical Technology Group LTD |
|
|
|
Date: August 25, 2025 |
By: |
/s/ Shuang Wu |
|
Name: |
Shuang Wu |
|
Title: |
Chief Executive Officer |
3